Идёт
Фаза III
Россия
Rucaparib; Nivolumab; Placebo Oral Tablet; Placebo IV Infusion · pharmaand GmbH
ATHENA (A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy)